Armin Sepp

674 total citations
36 papers, 484 citations indexed

About

Armin Sepp is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Armin Sepp has authored 36 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Armin Sepp's work include Monoclonal and Polyclonal Antibodies Research (18 papers), Protein purification and stability (11 papers) and Glycosylation and Glycoproteins Research (5 papers). Armin Sepp is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), Protein purification and stability (11 papers) and Glycosylation and Glycoproteins Research (5 papers). Armin Sepp collaborates with scholars based in United Kingdom, United States and Netherlands. Armin Sepp's co-authors include Andrew D. Griffiths, Dan S. Tawfik, Robert I. Lechler, Yen Choo, R M Binns, Thil Batuwangala, Andrew Sanderson, Guy Meno‐Tetang, Aliénor Berges and Chris Plummer and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Armin Sepp

30 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Armin Sepp United Kingdom 13 301 183 89 84 63 36 484
Rendall R. Strawbridge United States 9 344 1.1× 150 0.8× 48 0.5× 148 1.8× 37 0.6× 24 533
Stephanie Hanna United Kingdom 14 470 1.6× 89 0.5× 131 1.5× 90 1.1× 72 1.1× 25 785
Ina Theobald Germany 6 336 1.1× 197 1.1× 66 0.7× 30 0.4× 66 1.0× 7 459
D E Wylie United States 15 297 1.0× 119 0.7× 203 2.3× 52 0.6× 60 1.0× 18 647
Eshita Khera United States 12 191 0.6× 237 1.3× 42 0.5× 98 1.2× 223 3.5× 18 487
Uli Binder Germany 10 345 1.1× 190 1.0× 126 1.4× 34 0.4× 92 1.5× 12 564
Yuan-Chin Hsieh Taiwan 13 255 0.8× 139 0.8× 48 0.5× 101 1.2× 72 1.1× 27 464
Malaya Bhattacharya United States 14 348 1.2× 169 0.9× 149 1.7× 45 0.5× 54 0.9× 31 598
Yongshu Li China 14 362 1.2× 35 0.2× 103 1.2× 123 1.5× 138 2.2× 52 664
Lingbo Sun China 13 364 1.2× 48 0.3× 122 1.4× 49 0.6× 33 0.5× 21 475

Countries citing papers authored by Armin Sepp

Since Specialization
Citations

This map shows the geographic impact of Armin Sepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Sepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Sepp more than expected).

Fields of papers citing papers by Armin Sepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armin Sepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Sepp. The network helps show where Armin Sepp may publish in the future.

Co-authorship network of co-authors of Armin Sepp

This figure shows the co-authorship network connecting the top 25 collaborators of Armin Sepp. A scholar is included among the top collaborators of Armin Sepp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armin Sepp. Armin Sepp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sepp, Armin, et al.. (2025). The physiological limits of bispecific monoclonal antibody tissue targeting specificity. mAbs. 17(1). 2492236–2492236. 5 indexed citations
2.
Stader, Felix, et al.. (2025). Modeling and Simulation Identifies Endocytosis Uptake Rate and Fraction Unbound as Important Predictors of Oligonucleotide Pharmacokinetics. CPT Pharmacometrics & Systems Pharmacology. 14(12). 2065–2073.
3.
Stader, Felix, et al.. (2025). Cross-species translational modelling of targeted therapeutic oligonucleotides using physiologically based pharmacokinetics. Journal of Pharmacokinetics and Pharmacodynamics. 52(4). 35–35.
4.
5.
Jamei, Masoud, et al.. (2024). The role of automation in enhancing reproducibility and interoperability of PBPK models. Briefings in Bioinformatics. 26(1). 2 indexed citations
6.
Barber, Jill, Zubida M. Al‐Majdoub, Narciso Couto, et al.. (2023). Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling. European Journal of Pharmaceutical Sciences. 182. 106375–106375. 9 indexed citations
7.
Stach, Lasse, Ryan P. Bingham, Jo L. Bramhall, et al.. (2021). Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation. Antibodies. 10(4). 39–39. 1 indexed citations
8.
Thorneloe, Kevin S., Armin Sepp, Sean X. Zhang, et al.. (2019). The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans. EJNMMI Research. 9(1). 45–45. 16 indexed citations
9.
Sepp, Armin, et al.. (2019). Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats. Journal of Pharmacokinetics and Pharmacodynamics. 46(4). 339–359. 22 indexed citations
10.
11.
Sosabowski, Jane, Marie Davies, John D. Morrey, et al.. (2015). Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha. PLoS ONE. 10(2). e0117847–e0117847. 6 indexed citations
12.
Sepp, Armin, et al.. (2015). Stress selections on domain antibodies: 'What doesn't kill you makes you stronger'. Protein Engineering Design and Selection. 28(3). 59–66. 9 indexed citations
13.
Sosabowski, Jane, Armin Sepp, Marie Davies, et al.. (2013). Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain Antibodies. PLoS ONE. 8(2). e57263–e57263. 17 indexed citations
14.
Sepp, Armin & Andrew D. Griffiths. (2012). Cell-Free Selection of Domain Antibodies by In Vitro Compartmentalization. Methods in molecular biology. 911. 183–198. 3 indexed citations
15.
Batuwangala, Thil, et al.. (2009). Next generation immunotherapeutics—honing the magic bullet. Current Opinion in Biotechnology. 20(4). 405–411. 38 indexed citations
16.
Sepp, Armin & Yen Choo. (2005). Cell-free Selection of Zinc Finger DNA-binding Proteins Using In Vitro Compartmentalization. Journal of Molecular Biology. 354(2). 212–219. 35 indexed citations
17.
Sepp, Armin, Dan S. Tawfik, & Andrew D. Griffiths. (2002). Microbead display by in vitro compartmentalisation: selection for binding using flow cytometry. FEBS Letters. 532(3). 455–458. 84 indexed citations
18.
Sepp, Armin, Conrad A. Farrar, Anthony Dorling, et al.. (1999). Inhibition of expression of the Galα1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against α1,3Galactosyltransferase. Journal of Immunological Methods. 231(1-2). 191–205. 6 indexed citations
19.
Sepp, Armin, R M Binns, & Robert I. Lechler. (1996). Improved protocol for colorimetric detection of complement-mediated cytotoxicity based on the measurement of cytoplasmic lactate dehydrogenase activity. Journal of Immunological Methods. 196(2). 175–180. 36 indexed citations
20.
Sepp, Armin & Jaak Järv. (1991). Alkylation of acetylcholinesterase anionic centre with aziridinium ion accelerates the enzyme acylation step. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1077(3). 407–412. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rendall R. Strawbridge Breakdown of academic impact, for papers by Stephanie Hanna Breakdown of academic impact, for papers by Ina Theobald Breakdown of academic impact, for papers by D E Wylie Breakdown of academic impact, for papers by Eshita Khera Breakdown of academic impact, for papers by Uli Binder Breakdown of academic impact, for papers by Yuan-Chin Hsieh Breakdown of academic impact, for papers by Malaya Bhattacharya Breakdown of academic impact, for papers by Yongshu Li Breakdown of academic impact, for papers by Lingbo Sun
Rankless by CCL
2026